Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 13, 2005Virchows ArchivOpen Access

Stability of the HER2 gene after primary chemotherapy in advanced breast cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ZVZsuzsanna VargaRCRosmarie CaduffBPBernhard C. Pestalozzi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Varga et al. (2005) studied this question.

synapsesocial.com/papers/6a7bfdb8073f483584dfab42https://doi.org/10.1007/s00428-004-1164-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER22001 · 11,633 citations
  2. 2Assessment of Methods for Tissue-Based Detection of the HER-2/neu Alteration in Human Breast Cancer: A Direct Comparison of Fluorescence In Situ Hybridization and Immunohistochemistry2000 · 688 citations
  3. 3Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome2003 · 315 citations
  4. 4Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays2000 · 182 citations
  5. 5Induction chemotherapy for breast carcinoma: predictive markers and relation with outcome2003 · 84 citations